Skip to main navigation Skip to search Skip to main content

Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV

  • Giuseppina Li Pira
  • , Federico Ivaldi
  • , Nadia Starc
  • , Fabiola Landi
  • , Franco Locatelli
  • , Sergio Rutella
  • , Gino Tripodi
  • , Fabrizio Manca
  • IRCCS Ospedale pediatrico Bambino Gesù - Roma
  • Advanced Biotechnology Center
  • IRCCS Istituto Giannina Gaslini - Genova
  • MASIR Foundation

Research output: Contribution to journalArticle

Abstract

Monitoring of antigen-specific T-cell responses is valuable in numerous conditions that include infectious diseases, vaccinations, and opportunistic infections associated with acquired or congenital immune defects. A variety of assays that make use of peripheral lymphocytes to test activation markers, T-cell receptor expression, or functional responses are currently available. The last group of assays calls for large numbers of functional lymphocytes. The number of cells increases with the number of antigens to be tested. Consequently, cells may be the limiting factor, particularly in lymphopenic subjects and in children, the groups that more often require immune monitoring. We have developed immunochemical assays that measure secreted cytokines in the same wells in which peripheral blood mononuclear cells (PBMC) are cultured. This procedure lent itself to miniaturization and automation. Lymphoproliferation and the enzyme-linked immunosorbent spot (ELISPOT) assay have been adapted to a miniaturized format. Here we provide examples of immune profiles and describe a comparison between miniaturized assays based on cytokine secretion or proliferation. We also demonstrate that these assays are convenient for use in testing antigen specificity in established T-cell lines, in addition to analysis of PBMC. In summary, the applicabilities of miniaturization to save cells and reagents and of automation to save time and increase accuracy were demonstrated in this study using different methodological approaches valuable in the clinical immunology laboratory.
Original languageEnglish
Pages (from-to)488-495
Number of pages8
JournalClinical and Vaccine Immunology
Volume21
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • N/A

Fingerprint

Dive into the research topics of 'Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV'. Together they form a unique fingerprint.

Cite this